Crossmark

Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria

Crossref DOI link: https://doi.org/10.1186/s13613-019-0622-8

Published Print: 2020

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Kothekar, Amol T.

Divatia, Jigeeshu Vasishtha https://orcid.org/0000-0001-7384-4886
Myatra, Sheila Nainan

Patil, Anand

Nookala Krishnamurthy, Manjunath

Maheshwarappa, Harish Mallapura

Siddiqui, Suhail Sarwar

Gurjar, Murari

Biswas, Sanjay

Gota, Vikram
Funding

Funding for this research was provided by:

Tata Memorial Centre (Intramural grant)
License Information

Text and Data Mining valid from 2020-01-01

Text and Data Mining valid from 2020-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-019-0622-8

Content Type: article

Copyright: Copyright © 2020 The Author(s) 2020. Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below